4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-017729
Chief Financial Officer sold 7,954 shares at an average $101.31 ($805,814)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2026-02-17 | Sale 10b5-1 | −1,200 | $99.42 | $119,298 | 117,266 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-17 | Sale 10b5-1 | −200 | $100.52 | $20,104 | 117,066 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-17 | Sale 10b5-1 | −900 | $101.70 | $91,530 | 116,166 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-17 | Sale 10b5-1 | −1,069 | $103.00 | $110,110 | 115,097 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-17 | Sale 10b5-1 | −200 | $103.84 | $20,768 | 114,897 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-19 | Sale 10b5-1 | −1,308 | $100.27 | $131,153 | 113,589 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-19 | Sale 10b5-1 | −1,692 | $100.92 | $170,755 | 111,897 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-19 | Sale 10b5-1 | −800 | $102.10 | $81,676 | 111,097 | D |
| Smith Hunter C Chief Financial Officer | 2026-02-19 | Sale 10b5-1 | −585 | $103.28 | $60,420 | 110,512 | D |
| Open-market sales · 7,954 sh · avg $101.31 · $805,814 | |||||||
Loading xslF345X05/tm266887-1_4seq1.xml…